Table 3 Cost-effectiveness of L-APPE in our study patients
Parameter | Endoloop (n = 60) | Hem-o-lok (n = 60) | Stapler (n = 60) | P-value | Total (n = 180) |
|---|---|---|---|---|---|
Direct costs (Euro, mean ± SD) | 1705.4 ± 500.9 | 1624.9 ± 768 | 2120 ± 435 | < 0.001 | 1816.1 ± 624.3 |
Payments from health insurance companies (Euro, mean ± SD) | 1603.7 ± 227 | 1619.8 ± 355.6 | 1910.6 ± 350 | < 0.001 | 1711.8 ± 346 |
Profit (Euro, mean ± SD) | − 98.6 ± 487.4 | − 5.1 ± 761 | − 209.3 ± 412 | 0.0072 | − 104.3 ± 579.2 |